Adaptive Biotechnologies Employee Directory

Adaptive Biotechnologies corporate office is located in 1165 Eastlake Ave E, Seattle, Washington, 98109, United States and has 501-1,000 employees.

Likely to Engage tag.Highly Engaged Employees

Employees by Department

Departments

Number of employees

Engineering & Technical

71

Operations

61

Medical & Health

49

Sales

35

Information Technology

22

Human Resources

12

Finance

10

Adaptive Biotechnologies CEO

CR
United States flag for contact location.
Chad RobinsChief Executive Officer, Co-Founder & Chairman of the Board
PhonePhoneEmailEmail
See Profile

Key Employees of Adaptive Biotechnologies

Adaptive Biotechnologies Global Presence

globalPresence illustration
North America201-500
Europe1-10
South America1-10
Australia1-10
Africa1-10

Index of contact profiles from Adaptive Biotechnologies

Hundreds of professionals searching for Adaptive Biotechnologies have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12345

Former Employees at Adaptive Biotechnologies

Explore people who held key positions, contributed to Adaptive Biotechnologies's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in Washington, United States

Frequently Asked Questions Regarding Adaptive Biotechnologies Employees

How many employees does Adaptive Biotechnologies have?
Adaptive Biotechnologies has 501-1,000 employees
Who is the CEO of Adaptive Biotechnologies?
Adaptive Biotechnologies’s CEO is Chad Robins
Who is the CFO of Adaptive Biotechnologies?
Adaptive Biotechnologies’s CFO is Kyle Piskel
Who are Adaptive Biotechnologies key employees?
Some of Adaptive Biotechnologies key employees are Julie Rubinstein, Kyle Piskel
Where is Adaptive Biotechnologies located?
Adaptive Biotechnologies’s headquarters are located at 1165 Eastlake Ave E, Seattle, Washington, 98109, United States
How do I contact Adaptive Biotechnologies?
Adaptive Biotechnologies Contact Info: Phone number: (206) 659-0067 Website: www.adaptivebiotech.com
What does Adaptive Biotechnologies do?

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adapt... ive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.Read More

Is Adaptive Biotechnologies a public company?
Yes, Adaptive Biotechnologies is a public company and is traded under the symbol ADPT
See more information about Adaptive Biotechnologies Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.